Skip to main content
Free trial

Ask AI to review this stock

Copy the prompt to get recent events, historical reactions, and a short research brief.

Tell your AI:

Help me set up FinLab and analyze 1776 展宇. Please read: https://finlab.finance/en/setup?stock=1776

No install, open FinLab Studio

1776

展宇 Chemicals As of 2026-06-17 Updated daily after market close

steady quality, fair valuation.

1 active signal
252d high
This page refreshes daily after the close. Add 展宇 to your watchlist to track signal changes on your next visit.
Valuation 55Quality 61Growth 29Momentum 65Chips 80

Is 展宇 a buy? Fundamentals and valuation first

  • Above-average profitability.Operating margin is in the 61th market percentile. Latest quarterly ROE ≈ 2.5%.

  • Valuation is neutral.PE is in the 68th market percentile; within its own history, PE is around the 67th percentile.

  • Foreign investors are net buying.Foreign 20-day net flow ≈ 5.7% of volume (net buy).

  • Signals are active now.On the latest data, signals such as 252-day price high are active — see the historical forward returns after each occurrence below.

Chip flow

Bullish +0.43
BearishNeutralBullish

Single-sided accumulation, concentration rising — bullish

  • Single-sided accumulation, concentration rising — bullish
  • 台新 holds 336 lots
  • sellers have 262 lots left, ~111 sessions to clear

Window from 2026-01-17 · Price +19% · branches to 2026-06-17· TDCC to 2026-06-12

  • Largest holder 台新 has accumulated 336 lots since the start (sold 5%), now trimming.
  • Main distributor 臺銀-高雄 peaked at 138 lots, has sold 36%, 89 left, ~111 sessions to clear at the recent pace.
  • TDCC big holders (absolute) >1000-lot holders +0.89pp, mid holders +0, retail +0.01pp — concentration shifting upward.
  • Foreign hedge-desk net short Net short -5 lots (inferred from branch profile, mostly hedging — not necessarily bearish, not case-confirmed).
Branch inventory reconstruction
Accumulating holders Branches that accumulated shares during the window and still hold positive inventory; they are the absorbing side.
Distributing sellers Branches that built inventory earlier and have been selling it down; the remaining number estimates what has not cleared.
Net-short desks Trading-desk branches with negative inventory or net selling, often hedge, offsetting, or short-term flow. It is not automatically a bearish view.
Accumulating
台新群益金鼎-彰化凱基-台北國泰-台中合庫-自強兆豐-桃園
Distributing
臺銀-高雄台新-高雄台灣摩根士丹利元大-員林中山群益金鼎-海山國泰-館前
Desks
own scale
兆豐-竹北玉山-城中富邦-中壢富邦-八德
Price Accumulating & Distributing share one scale (comparable); Desks is independent. Zero is the baseline
Branch details Unit: lots

Accumulating

  • 台新 +336
    sold 5%
  • 群益金鼎-彰化 +182
    sold 0%· still adding
  • 凱基-台北 +162
    sold 24%· still adding
  • 國泰-台中 +160
    sold 0%· still adding
  • 合庫-自強 +80
    sold 0%
  • 兆豐-桃園 +68
    sold 7%

Distributing

  • 臺銀-高雄 89 left
    sold 36%· ~111 sessions to clear
  • 台新-高雄 72 left
    sold 29%· paused recently
  • 台灣摩根士丹利 65 left
    sold 34%· paused recently
  • 元大-員林中山 35 left
    sold 42%· ~23 sessions to clear
  • 群益金鼎-海山 18 left
    sold 66%· paused recently
  • 國泰-館前 24 left
    sold 51%· paused recently

Desks

  • 兆豐-竹北 -483
    unclassified
  • 玉山-城中 -124
    unclassified
  • 富邦-中壢 -106
    unclassified
  • 富邦-八德 -90
    unclassified
Still selling 262 lots ~111 sessions to bottom at most
Recent buy/sell force +734 absorbed / -158 sold buyers slightly ahead
Hedge-desk net short -5 lots potential cover-buying, not selling pressure
TDCC big holders · absolute-holding cross-check
>1000-lot holder share Retail (<400 lots) share Price (right axis)

Mixed direction: big-holder and retail changes are not aligned.

Describes chip flow, not investment advice. Branch data discloses only high-volume branches with ~1-day lag; TDCC is weekly. Inventory is a relative reconstruction from the window start, not absolute holdings.

Historical evidence

Signals active now

These signals are true on the latest data, with this stock's own historical forward-return stats after each occurrence.

252-day price high (breakout)

Active

Adjusted close makes a new 252-day high; repeats within 20 days counted once.

11 historical occurrences (since 2017-11-03)
Average forward return after 252-day price high (breakout)。20-day: Win 40%, Sample 10, Median -3.89%, Excess +2.87%, Beat mkt rate 40%；60-day: Win 33.3%, Sample 9, Median -1.62%, Excess -6.53%, Beat mkt rate 22.2%；120-day: Win 44.4%, Sample 9, Median -0.26%, Excess -1.34%, Beat mkt rate 33.3%

120 days after: historical avg +3.12%

20-day +3.58%
60-day -3.09%
120-day +3.12%
20-day
60-day
120-day
Win
40%
33.3%
44.4%
Sample
10
9
9
Median
-3.89%
-1.62%
-0.26%
Excess
+2.87%
-6.53%
-1.34%
Beat mkt rate
40%
22.2%
33.3%

Over 9 occurrences, 120-day forward avg gained 3.12%, lagged the market by 1.34 pts; win rate 44.4%.

Valuation regime and subsequent returns

Each day's PE is converted to its own-history percentile (as of that day), then we look at adjusted-close returns over the next 240 trading days by valuation regime.

PE percentile bandSample days240-day avg returnMedianWin rateAvg excess (vs index)
0-20 242-10% -13.3% 26.9% -5.6%
20-40 0Insufficient data
40-60 344-3.9% -6.4% 37.8% -33.7%
60-80 You are here391+21.2% +13.2% 90.8% -10.6%
80-100 399+5.8% +0.5% 53.4% -24.9%

Percentiles use an expanding own-history window (no look-ahead); forward return is 240 trading days on adjusted close. Sample days overlap; distribution is indicative only.

Current PE ≈ 38.27, at the 66.6th percentile of its own history (60-80 band).

Valuation × momentum historical grid

Every day in its own history is bucketed by valuation tercile (own-history PE) and 60-day momentum sign into six cells; we show adjusted-close returns over the next 120 trading days per cell.

Valuation
Momentum
Cheap (own-history bottom 1/3)
Mid
Expensive (own-history top 1/3)
60-day momentum up
-9.6%
Win rate 10.4% Excess -4.3%
106d
Now
+7.9%
Win rate 60% Excess -0.6%
345d
+2.9%
Win rate 52.6% Excess -10.1%
274d
60-day momentum down
-7.5%
Win rate 0.7% Excess +0.6%
136d
-0.8%
Win rate 38.6% Excess -21.9%
246d
+7.9%
Win rate 77.7% Excess -14.6%
385d

Currently in “Mid × 60-day momentum up”: across 345 historical days, 120-day forward avg gained 7.9%, win rate 60%, lagged the market by 0.6%.

Days = trading days in this bucket; returns use adjusted prices, ex-costs. 60-day momentum: direction of this stock's price over the past 60 trading days.

Signals not active (historical stats for reference)

These are not occurring now; historical samples shown for comparison.

Monthly revenue YoY ≥ 20% (from filing deadline)

Pending

Monthly revenue YoY ≥ 20%; event date is the first trading day after the filing deadline (no look-ahead).

18 times historically; 60-day forward avg +3.97%, win rate 53.3%, beating the market by +2.65 pts on average.

Foreign net buying for 5 straight days

Pending

Foreign net flow (ex-dealer) positive for 5 straight days; event on day 5; repeats within 20 days counted once.

19 times historically; 60-day forward avg +0.67%, win rate 53.3%, beating the market by -5.57 pts on average.

What does 展宇 do? Company profile

化學工業；聚氨酯材料、PU合成樹脂、TPU塑粒 上市（台灣證券交易所）

Overview

1776 對應證券為台灣證券交易所上市普通股「展宇」，公司全名展宇科技材料股份有限公司，英文名 Headway Advanced Materials Inc.。公司成立於 1976/04/24，前身為展宇化學工業有限公司，2001 年更名為展宇科技材料股份有限公司；2004 年登錄興櫃，2016/05/09 於台灣證券交易所掛牌上市。總部與主要地址為新竹縣湖口鄉鳳凰村光復路71號（新竹工業區），電話 03-5978899，統一編號 47061800。董事長為劉漢瀛，總經理為趙偉君，發言人為廖培宏。實收資本額約新台幣 601,069,520 元，已發行普通股約 60,106,952 股。員工規模依 2024 年報為 2024 年 206 人、2025/03/31 為 200 人。公司官網主要股東資料日為 2025/03/29，前十大股東包含近藤投資 8.92%、遊龍投資 5.48%、鄭陳興業 4.19%、神算投資 3.70%、王瑞麟 3.24%、劉漢瀛本人 2.89%、通慶投資 2.67%、劉建宏 2.31%、劉彥均 2.19%、李煌寶 1.82%。公司在台灣、上海、廣東、越南建立產銷與服務據點；關係企業包含展宇聚氨酯、上海匯宇建築工程、佛山市三水聯美化工、展宇科技材料（越南）等。

Business

展宇是聚氨酯材料中游製造商，主要生產與銷售 PU 樹脂、PU 硬化劑/架橋劑、TPU 塑粒，以及部分膠膜與特用化學品。2024 年營業比重依公司 2024 年報：PU 樹脂銷售額 965,935 千元、占 77.90%；熱可塑性聚氨酯（TPU）塑粒 172,279 千元、占 13.89%；其他 101,827 千元、占 8.21%；合計銷貨淨額 1,240,041 千元。PU 樹脂包含溶劑型 PU 樹脂、水性 PU 樹脂、無溶劑 PU 樹脂等；產品可供下游紡織上膠與貼合、油墨、皮革、塑料加工、塗料、工程建材、發泡模塑、彈性體加工、塑料押出/拉出/壓延等用途。終端應用包含運動鞋、透濕防水機能衣、家具、建材、紡織合成皮革、包裝、印刷、機車汽車零件、運動器材、醫療材料等。商業模式為採購 TDI、MDI、AA、EAC、多元醇、溶劑、PET 膜等石化中間原料，經配方研發與聚氨酯合成/加工，銷售給亞太地區加工製造商；銷售地區以台灣、中國大陸、越南等亞太市場為主，近年積極拓展東南亞與印度市場。年報揭露 2024 年有一名隱名主要客戶「甲公司」占銷貨淨額 11.83%，2025 年第一季占 12.61%，但未揭露實際公司名稱。

Outlook 2025–2028

2025 至 2028 年展望重點在產品組合高值化、環保材料替代與東南亞/印度市場拓展。成長動能包括：一、環保法規與品牌供應鏈要求趨嚴，NIKE、ADIDAS、NB、PUMA 等品牌推動 ZDHC 有害物質零排放，帶動水性 PU、無溶劑 PU、TPU 等低溶劑/環保型材料需求；二、公司短期計畫持續開發差異化、高值化 PU 樹脂與 TPU 塑粒，並在華南、台灣、越南形成服務網路；三、越南廠與東南亞據點受惠 RCEP、鞋業、紡織、家具等供應鏈移轉，作為拓展東南亞、印度及印尼市場的基地；四、研發方向包含環保皮革組合、PUR 無溶劑反應型熱熔膠、生質/回收多元醇 PUR、Bluesign 規格紡織用 PUR、水性 PU、高耐水解/高耐折產品、食品包裝油墨、醫療復健器材與血液透析用封裝彈性體等。2025 年公司法說與市場資料顯示，公司曾主動降低低獲利、非環保型產品銷售，聚焦高值化環保型產品，毛利率有所改善；2026 年前 5 月營收約 4.55 億元、年增約 0.97%，短期需求仍需觀察。主要風險包括：原料成本占生產成本高，AA、MDI、DMF、TDI 等價格受國際石化景氣與供需波動影響，且 TDI、MDI 國內無廠商生產、需依賴進口；中國市場成本上升、低價競爭、環保與安全生產壓力增加；化工環保法規趨嚴會壓縮溶劑型產品推廣；全球貿易摩擦、終端鞋材/紡織/家具需求波動及匯率亦可能影響營收與毛利。2027-2028 年具體財務預測未見公司公開定量指引，因此不杜撰數字。

Supply Chain

Upstream
  • 台灣巴斯夫／BASF 年報列為 TDI、AA、MDI 等主要原料供應來源之一；BASF 為外商/非台股掛牌公司，年報亦揭露 BASF 為 2024 年主要進貨供應商，占進貨淨額約 14.10%。
  • Mitsubishi Chemical／三菱化學 年報列為 MDI 供應商之一；日本企業，非台股掛牌。
  • Huafon／華峰 年報列為 AA 供應商之一；非台股掛牌，供應關係依公司年報。
  • Celanese 年報列為 EAC 供應商之一；外商，非台股掛牌。
  • 石化原料與多元醇供應商 公司上游原料包含石化原料、TDI、MDI、AA、聚酯多元醇、聚醚多元醇、各類多元醇、EAC、TMP、甲乙酮與各類溶劑；多數為國際或未揭露供應商，無法逐一確認是否為直接供應商。
Downstream
  • 甲公司（年報隱名主要客戶） 公司年報揭露 2024 年單一主要客戶「甲公司」占銷貨淨額 11.83%，2025 年第一季占 12.61%，但未公開實名，無法確認是否台股掛牌。
  • 鞋材、合成皮革與皮革加工製造商 下游加工客戶類型；使用 PU 樹脂/TPU 於鞋底、鞋面、鞋材油墨、合成皮、真皮表面處理、防水布與透濕防水機能布等，未確認具名直接客戶。
  • 紡織、貼合、油墨與塗料加工製造商 下游加工客戶類型；使用水性 PU、無溶劑 PU、PUR、PU 硬化劑/架橋劑於紡織貼合、油墨、塗料與建材等，未確認具名直接客戶。
  • 家具、建材、運動器材、醫療材料加工製造商 終端應用產業包含家具、建材工程、運動器材、醫療復健器材與血液透析用封裝彈性體等；目前僅能確認為應用領域，非具名直接客戶。

Competitors

  • 榮化 1704 台股上市化工公司，StockFeel 將其列為樹脂相關同業競爭對手；產品組合與展宇並非完全相同。
  • 長興 1717 台股上市樹脂與電子材料公司，屬合成樹脂/化學材料同業。
  • 三晃 1721 台股上市化工公司，涉及樹脂、接著劑與化學材料相關業務。
  • 日勝化 1735 台股上市化工公司，StockFeel 列為樹脂相關競爭對手。
  • 上緯投控 3708 台股上市複合材料樹脂與綠能材料相關公司，與展宇在樹脂材料領域有部分競合。
  • 永純 4711 台股上櫃合成樹脂公司，屬樹脂材料同業。
  • 永捷 4714 台股上櫃化學材料公司，StockFeel 列為展宇樹脂業務競爭對手。
  • 大立 4716 台股上櫃化學材料公司，屬樹脂/化工材料相關同業。
  • 德淵 4720 台股上櫃接著劑與特用化學材料公司，與 PU、接著材料應用領域有部分競合。
  • 國精化 4722 台股上櫃樹脂與特用化學材料公司，屬樹脂材料同業。
  • 雙邦 6506 台股上櫃聚氨酯樹脂、機能性材料與紡織塗佈材料公司，與展宇在 PU/TPU 及機能性材料應用上具可比性。
Sources（13）

This company profile is compiled from public sources (annual reports, filings, news and analyst reports), not finlab backtest data; the 2025–2028 outlook contains forward-looking estimates and is for reference only.

Method and limitations

  • All returns use adjusted close (etl:adj_close), already adjusted for dividends and splits.
  • Excess return is measured against the TAIEX total-return index (dividends included).
  • Valuation regime and percentile stats use an expanding own-history window (no future data).
  • Revenue-signal event dates align to the first trading day after the filing deadline, avoiding look-ahead.
  • Event samples may overlap in time; stats describe historical distribution only and are less reliable when samples are few.

This page is historical statistics for educational purposes and is not investment advice. Investing involves risk; past performance does not indicate future results. Assess and bear the risk yourself before trading.